Derya Kıvrak Salim - Concepedia

Author

Derya Kıvrak Salim

Also Known As

D Salim, D. Kivrak Salim, DERYA KIVRAK SALIM, Danyal Salim, Denis Salim, Derya K Salim, Derya KIVRAK SALIM, Derya KIVRAK SALİM, Derya Kivrak Salim, Derya Krvrak Salim

Publications

313

Citations

H-Index

Concepts

All Affiliations

Akdeniz University Antalya Eğitim ve Araştırma Hastanesi Kocaeli Üniversitesi Kahramanmaraş Sütçü İmam University Ankara University

About

Derya Kıvrak Salim is an author at Akdeniz University specializing in cancer research, tumor microenvironment, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	37
2	Immunology	1	1	37
3	Pathology	1	1	37
4	Head And Neck Cancer	1	1	37
5	Cancer Research	1	1	37

Derya Kıvrak Salim

Publications

196

Citations

H-Index

Page 1

	Year	Citations
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer Derya Kıvrak Salim, Hasan Mutlu, MELEK KARAKURT ERYILMAZ, Molecular and Clinical Oncology Cancer ImmunosurveillanceNlr ≤2.93MedicineMalignant Blood DisorderPrognosis	2015	37
The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Melek Karakurt Eryılmaz, Hasan Mutlu, Derya Kıvrak Salim, Asian Pacific Journal of Cancer Prevention	2014	37
Local Immune Response in Helicobacter pylori Infection Derya Kıvrak Salim, Mehmet Şahin, Sadi Köksoy, Medicine	2016	30
Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35) Sema Sezgin Göksu, Didem Taştekin, Deniz Arslan, Asian Pacific Journal of Cancer Prevention	2014	25
Molecular Types and Neoadjuvant Chemotherapy in Patients with Breast Cancer- While Molecular Shifting is More Common in Luminal a Tumors, The Pathologic Complete Response is Most Frequently Observed in Her-2 Like Tumors Derya Kıvrak Salim, Hasan Mutlu, Melek Karakurt Eryılmaz, Asian Pacific Journal of Cancer Prevention	2014	23
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci, BMC Cancer	2023	23
Predictive and Prognostic Value of Inflammatory and Nutritional Indexes in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy Mustafa Özgür Arıcı, Derya Kıvrak Salim, Murat Koçer, Medicina	2024	11
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut, The Oncologist	2023	10

Page 1